ReviewCureus2023

Efficacy and Safety of Palivizumab as a Prophylaxis for Respiratory Syncytial Virus (RSV) Disease: An Updated Systemic Review and Meta-Analysis.

Khaled El-Atawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.